Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Wound Healing Abnormalities in Major Abdominal Surgery (INWOUND)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Klinikum St. Georg gGmbH
Information provided by (Responsible Party):
Armin Sablotzki, MD, Klinikum St. Georg gGmbH Identifier:
First received: August 14, 2008
Last updated: December 27, 2015
Last verified: December 2015
This clinical observational study investigates the incidence of wound healing abnormalities in patients undergoing major abdominal surgery. Second aim of the study is, if wound healing deficits may be accompanied by abnormalities in blood coagulation parameters.

Impaired Wound Healing
Factor XIII Deficiency

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Incidence of Wound-healing-abnormalities in Major Abdominal Surgery - Association With Factors of Coagulation

Resource links provided by NLM:

Further study details as provided by Klinikum St. Georg gGmbH:

Primary Outcome Measures:
  • Incidence of wound healing abnormalities [ Time Frame: from baseline to postoperative day 28 ] [ Designated as safety issue: No ]
    Occurence of wound healing abnormalities within the first 28 days after surgery

Secondary Outcome Measures:
  • Abnormalities in coagulation parameters [ Time Frame: postoperative day 28 ] [ Designated as safety issue: No ]
    occurence of low platelets (<60.000) or factor XIII < 50% between the first and seventh postoperative day

Biospecimen Retention:   Samples Without DNA
1) serum samples for measurement of coagulation factors

Estimated Enrollment: 260
Study Start Date: July 2008
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)
Study group
Patients undergoing major abdominal surgery


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients undergoing major abdominal surgery

Inclusion Criteria:

  • Age >= 18 years
  • Male or female
  • Informed consent
  • Major abdominal surgery

Exclusion Criteria:

  • Pre-existing coagulation abnormalities
  • Pre-existing severe renal or liver failure
  • Chemo- or radiochemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00735579

Contact: Armin R Sablotzki, MD 0049-341-9092570
Contact: Elke G Czeslick, MD 0049-341-9092570

Klinikum St. Georg gGmbH Recruiting
Leipzig, Sachsen, Germany, 04105
Contact: Armin R Sablotzki, MD    0049-3419092570   
Sub-Investigator: Ralf Kleczewski, MD         
Sponsors and Collaborators
Klinikum St. Georg gGmbH
Principal Investigator: Armin R Sablotzki, MD Klinikum St. Georg gGmbH
  More Information

Additional Information:
Responsible Party: Armin Sablotzki, MD, Prof. Dr. med., Klinikum St. Georg gGmbH Identifier: NCT00735579     History of Changes
Other Study ID Numbers: EK-BR-21/08-1  Stu08/0022 
Study First Received: August 14, 2008
Last Updated: December 27, 2015
Health Authority: Germany: Ethics Commission

Keywords provided by Klinikum St. Georg gGmbH:
major abdominal surgery
extracellular matrix proteins
wound healing after major abdominal surgery

Additional relevant MeSH terms:
Wounds and Injuries
Factor XIII Deficiency
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn processed this record on October 26, 2016